Home >

Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

LOGIN TO START A DISCUSSION
Filter by Molecular Oncology Tumor Board
Molecular Oncology Tumor Board
ASCO University
Mar 09, 2016 9:36 AM
Read more to answer the following questions: 1) What molecular testing on tissue should be performed in newly diagnosed DLBCL? 2) How need for molecular testing affects tissue requirements and biopsy size? 3) What staging studies and serum biomarkers would you obtain?  
Molecular Oncology Tumor Board
ASCO University
Feb 10, 2016 9:49 AM
Read more to answer the following questions: 1) Choice for site of biopsy? LN vs. Bone and merits/pros/cons for tissue for molecular profiling vs. confirmation of distant recurrence? 2) Would you recommend clinical genetics consultation for BRCA testing?  Expanded panel testing? 3) What additional...
Molecular Oncology Tumor Board
ASCO University
Jan 13, 2016 9:19 AM
Read more to answer the following questions: 1) What are the pathologic features that distinguish PEComa from the much more common leiomyosarcoma? 2) What is the role for cytotoxic chemotherapy in the treatment of metastatic or unresectable PEComa? 3) Are there any particular genetic targets...
Molecular Oncology Tumor Board
ASCO University
Dec 02, 2015 10:12 AM
Read more to answer the following questions: 1) Who should get routine molecular testing at diagnosis for NSCLC and what tests should be performed? 2)  Given this patient’s age and smoking history are you surprised at the finding of an EGFR mutation? 3) What is the most appropriate initial...
Molecular Oncology Tumor Board
ASCO University
Nov 04, 2015 10:35 AM
Read more to answer the following questions: 1) Does this tumor have a variant morphology and is it significant clinically? 2.) What are the diagnostic/staging studies at this point? 3.) What are treatment options for this patient? 4.) Which tumor gene mutational analysis, if any, might aid in...

Pages